Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.08
+0.08 (1.00%)
At close: Jul 14, 2025, 4:00 PM
8.08
0.00 (0.00%)
After-hours: Jul 14, 2025, 4:30 PM EDT
Bicycle Therapeutics Employees
Bicycle Therapeutics had 305 employees as of December 31, 2024. The number of employees increased by 21 or 7.39% compared to the previous year.
Employees
305
Change (1Y)
21
Growth (1Y)
7.39%
Revenue / Employee
$84,334
Profits / Employee
-$666,302
Market Cap
559.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCYC News
- 12 days ago - Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting - Business Wire
- 2 months ago - Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - Business Wire
- 2 months ago - Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025 - Business Wire
- 2 months ago - Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted - Seeking Alpha
- 3 months ago - Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 3 months ago - Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments - Business Wire
- 4 months ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - Business Wire